Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
The protocol for the original gabapentin review (Wiffen 2005) was superceded and split, and an updated protocol produced for the 2011 review (Moore 2011a), to reflect, at least in part, the more recent developments in understanding of potential biases in chronic pain trials, and new outcomes of direct relevance to people with neuropathic pain. Abstract Background: This review is an update of a review published in 2011, itself a major update of previous reviews published in 2005 and 2000, investigating the effects of gabapentin in chronic neuropathic pain (pain due to nerve damage). Antiepileptic drugs are used to manage chronic neuropathic pain and fibromyalgia. Background: Gabapentinoids are commonly prescribed to control neuropathic pain of lumbar radiculopathy. Few trials have compared the efficacy of gabapentin (GBP) and pregabalin (PGB). Therefore, the authors conducted a meta-analysis to compare the difference in effect between GBP and PGB in lumbar radiculopathy patients. Methods: Articles which were published between January 1, 1960 and May 31 This review replaces part of an earlier review that evaluated gabapentin for both neuropathic pain and fibromyalgia, now split into separate reviews for the two conditions. This review will consider pain in fibromyalgia only. Fibromyalgia is associated with widespread pain lasting longer than three months, and is frequently associated with symptoms such as poor sleep, fatigue, depression, and Gabapentin add-on treatment for drug-resistant focal epilepsy. Cochrane Database Syst Rev 2021;1:CD001415. 10.1002/14651858.CD001415.pub4 [DOI] [PMC free article] [PubMed] [Google Scholar] 13. Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, et al. Trial of Pregabalin for Acute and Chronic Sciatica. In this review, we summarised the evidence from randomised controlled trials (RCTs) of gabapentin, when used as an add-on treatment for drug-resistant focal epilepsy. For the present review, researchers in The Cochrane Collaboration reviewed the evidence about the effects of gabapentin and two related drugs (pregabalin and gabapentin enacarbil) in adult patients (≥ 16 years of age) with 'episodic' migraine (headache on < 15 days per month). Keywords: Gabapentin, Meta-analysis, Neuralgia, Neuropathic pain, Pregabalin, Systematic review Impact statements This systematic review and meta-analysis identified, for the first time, that the majority of adverse events with gabapentinoids were associated with their effect on the nervous system. This review updates parts of two earlier Cochrane reviews investigating effects of gabapentin in chronic neuropathic pain (pain due to nerve damage). Antiepileptic drugs are used to manage pain, predominantly for chronic neuropathic pain, especially Background: Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage). This review updates a review published in 2014, and previous reviews published in 2011, 2005 and 2000. Objectives: To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain in adults. Search methods: For this update we searched CENTRAL), MEDLINE, and Embase for The Cochrane Library is a collection of high-quality, independent evidence to inform healthcare decision-making, including the Cochrane Database of Systematic Reviews and the CENTRAL register of controlled trials. Abstract Background: This review updates parts of two earlier Cochrane reviews investigating effects of gabapentin in chronic neuropathic pain (pain due to nerve damage). Antiepileptic drugs are used to manage pain, predominantly for chronic neuropathic pain, especially when the pain is lancinating or burning. For the present review, researchers in The Cochrane Collaboration reviewed the evidence about the effects of gabapentin and two related drugs (pregabalin and gabapentin enacarbil) in adult patients (≥ 16 years of age) with 'episodic' migraine (headache on < 15 days per month). This review is an update of a review published in 2011, itself a major update of previous reviews published in 2005 and 2000, investigating the effects of gabapentin in chronic neuropathic pain (pain due to nerve damage). Antiepileptic drugs are Wiffen et al (2017) conducted a meta-analysis seeking to assess the efficacy of gabapentin, an antiepileptic agent, in relieving chronic neuropathic pain in adults. In addition, the authors also assessed the adverse effects of the drug.. Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage). This review updates a review published in 2014, and previous reviews published in 2011, 2005 and 2000. To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain in adults. Background Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage). This review updates a review published in 2014, and previous reviews published in 2011, 2005 and 2000. Objectives To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain in adults. Search methods For this update we searched CENTRAL), MEDLINE, and Embase for The Cochrane Review 1 summarized in this Cochrane Rehabilitation Corner addresses analgesic efficacy and harms of gabapentin for adults experiencing chronic neuropathic pain. For the present review, researchers in The Cochrane Collaboration reviewed the evidence about the effects of gabapentin and two related drugs (pregabalin and gabapentin enacarbil) in adult patients (≥ 16 years of age) with 'episodic' migraine (headache on < 15 days per month). Can Gabapentin Alleviate Chronic Neuropathic Pain in Adults?: A Cochrane Review Summary With CommentaryAm J Phys Med Rehabil. 2020 Jun;99 (6):558-559. doi: 10.1097/PHM.0000000000001420.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |